Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

191.20
Delayed Data
As of 3:59pm ET
 -2.95 / -1.52%
Today’s Change
119.37
Today|||52-Week Range
199.95
+49.33%
Year-to-Date
4 Hot ETF Charts of Q2 Earnings Season
Aug 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close194.15
Today’s open193.59
Day’s range191.16 - 195.83
Volume659,906
Average volume (3 months)1,025,861
Market cap$28.4B
Dividend yield--
Data as of 3:59pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+9.63%
Earnings growth (next 5 years)+14.41%
Revenue growth (last year)+8.05%
P/E ratio38.3
Price/Sales7.90
Price/Book12.92

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc-2.06-1.61%
BIVVBioverativ Inc-2.17-3.80%
NBIXNeurocrine Bioscienc...-0.43-0.80%
EXASExact Sciences Corp-1.20-3.10%
Data as of 3:59pm ET, 08/17/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$1.01
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Executive VP-Operations, Products &
Strategy
Ostadan Omead
Corporate headquarters
San Diego, California

Forecasts